Turning the tide against tuberculosis

- Tuberculosis (TB) remains an enormous public health concern.
- There is a large disparity in investment between TB and HIV.
- Scientific advances are inadequate to achieve the World Health Organization's goal to end TB by 2035.
- This article highlights the consequences of a conventional biomedical approach to TB.

SummaryDespite affecting men, women, and children for millennia, tuberculosis (TB) is the most neglected disease. In contrast, the global response to HIV has reached a defining moment. By uniting efforts, promptly integrating major scientific findings for both treatment and prevention, and scaling up services, the once inconceivable end to the HIV epidemic may no longer be an illusion. “The world has made defeating AIDS a top priority. This is a blessing. But TB remains ignored” − Nelson Mandela. While there is no doubt that revolutionary diagnostics and new and repurposed drugs have provided some hope in the fight against TB, it is evident that scientific advances on their own are inadequate to achieve the World Health Organization's ambitious goal to end TB by 2035. In this article, the consequences of a myopic and conventional biomedical approach to TB, which has ultimately permeated to the level of individual patient care, are highlighted.